Eclipse PRP® is a proprietary system that is based on blood separation according to density using a unique separation gel. The PRP platform is available with an 11 mL PRP collection tube or 22 mL high concentration collection tube. The system allows for the preparation of pure Platelet-Rich Plasma (PRP) with optimal platelet concentrations and cellular content. Virtually, all Red Blood Cells (RBC) are eliminated from PRP and the concentration of pro-inflammatory Granulocytes (GRs) is highly reduced.
Platelet-Rich Plasma is prepared by taking a small sample of the patient’s own blood, then separating platelets from Platelet-Poor Plasma (PPP), RBC and GRs via centrifugation. Next, the PRP is collected and may be applied to the treated site. The whole preparation process only takes up to 20 minutes.
Platelet-Rich Plasma (PRP) is an autologous concentrated preparation of platelets and the associated growth factors in a small volume of plasma. Platelets are a natural source of a number of growth factors in their natural and biologically-determined ratios.
Upon activation, platelets release growth factors and other molecules. These growth factors are regeneration-promoting signaling molecules, such as Platelet-Derived Growth Factor (PDGF), Transforming Growth Factor group (TGF), Epidermal Growth Factor (EGF), Vascular Endothelial Growth Factor (VEGF), Fibroblast Growth Factor (FGF) and others. These molecules are shown to regulate the healing cascade, including inflammation and cell proliferation.
Regulatory Status: FDA cleared 510(k) Class II medical device. Eclipse PRP® is intended for the safe and rapid preparation of autologous platelet-rich plasma (PRP) from a small sample of blood at the patient point of care. The PRP is mixed with autograft or allograft bone prior to application to an orthopedic surgical site. 510(k) number: BK110035
To receive a consultation, request your appointment online and schedule your visit during one of the select times our surgeons have set aside exclusively for Web visitors.